Ioannis Chatzizisis, MD, PhD
Basic profileIoannis Chatzizisis is a Cardiology physician affiliated with University of Miami.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- CathWorksProgram year20254 paymentsResearch$36,243
- MedtronicProgram year20251 paymentResearch$16,560
- HEARTFLOW, INC.Program year20257 payments$1,784
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78.6%Statin22%Rosuvastatin Calcium65%Atorvastatin Calcium35%Part D≥34 patientsBeta blocker10.7%Metoprolol Succinate44%Metoprolol Tartrate38%Carvedilol18%Part D<11 patients+ 11 more classes in this area
Blood & clotting
13.9%Factor Xa inhibitor6.9%Eliquis100%Part D<11 patientsP2Y12 inhibitor6.9%Clopidogrel100%Part D≥15 patientsMetabolism & gastrointestinal
7.6%SGLT2 inhibitor7.6%Farxiga63%Jardiance38%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2023–2023 per NIH RePORTER. The latest:
- Patient-Specific Simulations to Guide Coronary Bifurcation Stenting
University of Miami School of Medicine
FY2023$770,637R01HL144690
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Myron Ginsberg, MD
University of Miami
Carlos Singer, MD
University of Miami
Cynthia Levy, MD
University of Miami
Gwendolyn Scott, MD
University of Miami
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Gregg Fonarow, MD
Ronald Reagan UCLA Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”